Key result
~64% of ACS patients choose CYP2C19 genotyping, driven by doctor recommendations and reduced cardiovascular risk.
Why the study?
The study was conducted to evaluate the relative importance of CYP2C19 genotype-guided treatment attributes to patients.
What are the relative importances of CYP2C19 genotype-guided treatment attributes to patients with acute coronary syndrome?
Cross-Sectional (n=63)
What are the relative importances of CYP2C19 genotype-guided treatment attributes to patients with acute coronary syndrome?
Patients with acute coronary syndrome value doctor's recommendations and reduced ischemic risk highly when considering CYP2C19 genotyping, with a majority opting for genotyping.
Answers are grounded in this paper and cite their sources.
May inform shared decisions on CYP2C19 genotyping in ACS; leaves open effects on outcomes.
Aim: To evaluate the relative importance of CYP2C19 genotype-guided treatment attributes to patients. Patients & methods: A discrete choice experiment questionnaire was administered to 63 patients with acute coronary syndrome. Attributes examined in the discrete choice experiment questionnaire were: cost of genetic testing (S$50, S$100, S$200); cost of antiplatelet medication (S$100, S$500, S$1000); heart attack or stroke risk (5 in 100, 15 in 100, 25 in 100); bleeding risk (5 in 100, 15 in 100, 25 in 100); doctor’s recommendation (yes, neutral). Mixed logit model was used for analysis. Results & conclusion: All attributes were important in patients’ decision-making. Most displayed strong preference for doctor’s recommendation and reduced heart attack or stroke risk. Genotyping was chosen by 63.5% of the patients.
No takes yet. Share an insight, caveat, or question.
Wee et al. (2020) conducted a cross-sectional in Acute Coronary Syndrome (n=63). CYP2C19 genotyping was evaluated on Choice of genotyping. CYP2C19 genotyping was chosen by 63.5% of patients with acute coronary syndrome, who displayed strong preferences for doctor's recommendation and reduced heart attack or stroke risk.
Synapse has enriched 10 related papers. Consider them for comparative context: